G904-0379 Screening compound: N-[(pyridin-2-yl)methyl]-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)benzamide

G904-0379 Screening compound: N-[(pyridin-2-yl)methyl]-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)benzamide
G904-0379 Screening compound: N-[(pyridin-2-yl)methyl]-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G904-0379
N-[(pyridin-2-yl)methyl]-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G904-0379

Molecular Formula

C23H24N4O2 (C23 H24 N4 O2)

Compound Name

N-[(pyridin-2-yl)methyl]-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)benzamide

IUPAC name

N-[(pyridin-2-yl)methyl]-4-(366-trimethyl-4-oxo-4567-tetrahydro-1H-indazol-1-yl)benzamide

SMILES

CC(C)(Cc1c2c(C)nn1-c(cc1)ccc1C(NCc1ncccc1)=O)CC2=O

InChI

InChI=1S/C23H24N4O2/c1-15-21-19(12-23(2,3)13-20(21)28)27(26-15)18-9-7-16(8-10-18)22(29)25-14-17-6-4-5-11-24-17/h4-11H,12-14H2,1-3H3,(H,25,29)

InChI Key

VLBSISWHLVWCNP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15074736

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

388.47

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.264

Distribution Coefficient, logD

2.264

Water Solubility, LogSw

-2.62

Polar Surface Area

61.766

Acid Dissociation Constant (pKa)

11.30

Base Dissociation Constant (pKb)

3.36

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.40

G904-0379 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with G904-0379 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G904-0379?
Check Price and Availability of G904-0379, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G904-0379 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G904-0379
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G904-0379
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G904-0379 available by request